FDA Inspection
Allergan Pharmaceuticals IrelandAllergan Pharmaceuticals Ireland – FDA Inspection, Jan 30, 2025
Record Details
This FDA Inspection record concerns Allergan Pharmaceuticals Ireland, with an inspection on January 30, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 5cd0cdac-a1ee-429c-bf97-7a8c1777a54a
Inspection Facts
- Inspection number
- 1259046
- FDA center
- Human Drugs
Other FDA inspections of Allergan Pharmaceuticals Ireland
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 4, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 3, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 11, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Allergan Pharmaceuticals Ireland
- FDA Inspection 1194596 - 2022-06-17
- FDA Inspection 1117366 - 2018-05-04
- FDA Inspection 1002463 - 2016-12-16
- FDA Inspection 933338 - 2015-07-03
- FDA Inspection 842267 - 2013-07-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.